Holen Sie sich die Stockscreener-App
84.77
0.78%
0.7962
Schlusskurs vom Vortag:
$83.97
Offen:
$83.96
24-Stunden-Volumen:
307.16K
Relative Volume:
0.26
Marktkapitalisierung:
$9.43B
Einnahmen:
$13.38B
Nettoeinkommen (Verlust:
$418.00M
KGV:
25.60
EPS:
3.3112
Netto-Cashflow:
$391.00M
1W Leistung:
-1.05%
1M Leistung:
-4.40%
6M Leistung:
+15.87%
1J Leistung:
+29.01%
1-Tages-Spanne:
$83.30
$85.28
1-Wochen-Bereich:
$83.30
$86.78
52-Wochen-Spanne:
$61.95
$92.18
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
84.65 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
892.32 | 101.04B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
309.24 | 58.57B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
228.43 | 50.99B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
0.987 | 642.53M | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | BTIG Research | Neutral |
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-02-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein credit supervisor sentenced to prison for embezzling $1.6M from Melville company - Newsday
Henry Schein Q2FY26 Results: Non-GAAP EPS up 15.5%, guidance raised - scanx.trade
Transcript: Henry Schein Q2 2026 Earnings Conference Call - Benzinga
Is Henry Schein Stock Outperforming the Dow? - inkl.com
Henry Schein stock trades below its yearly high after Q2 figures - AD HOC NEWS
Henry Schein stock heads into the open after closing at USD 85.05 - AD HOC NEWS
Henry Schein credit supervisor sentenced to 2 1/2 years in prison for embezzling $1.6M from Melville company - Newsday
Henry Schein stock trades at USD 85.56 after Q2 guidance - AD HOC NEWS
Can Henry Schein (NASDAQ:HSIC) Hold Today’s Attention? - Kalkine Media
Henry Schein stock heads into the open after a 0.47 percent drop - AD HOC NEWS
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein stock falls 2.72 percent despite higher guidance - AD HOC NEWS
Henry Schein Expands and Extends Revolving Credit Facility - The Globe and Mail
Henry Schein stock gains 0.42 percent ahead of the open - AD HOC NEWS
Henry Schein, Inc. Amends and Restates $1 Billion Revolving Credit Agreement to Increase Commitments to $1.25 Billion - marketscreener.com
Henry Schein stock gains as credit facility expands - AD HOC NEWS
Henry Schein Expands Revolving Credit Facility to $1.25 Billion - Minichart
Henry Schein Expands Revolving Credit Facility to $1.25 Billion, Extends Maturity to 2031 - TradingView
Henry Schein stock steady after recent earnings update - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Analysis: A Promising 15.73% Upside in the Healthcare Sector - DirectorsTalk Interviews
Henry Schein stock heads into the open after a 0.3 percent dip - AD HOC NEWS
Henry Schein stock holds steady as investors eye latest earnings and valuations - AD HOC NEWS
Henry Schein Still Gives Me A Reason To Smile After This Nice Move Higher (NASDAQ:HSIC) - Seeking Alpha
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - fortune.com
Are Investors Undervaluing Henry Schein (HSIC) Right Now? - Eastern Progress
Henry Schein stock heads into the open after a 1.99% drop - AD HOC NEWS
Henry Schein stock heads into the open after a 0.6 percent gain. - AD HOC NEWS
What Makes Henry Schein (HSIC) a New Buy Stock - Yahoo Finance
Henry Schein: Growth Is Improving, But The Valuation Stays Cheap (NASDAQ:HSIC) - Seeking Alpha
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring an 11.12% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Henry Schein Inc Share PriceHSIC, RNS News, Articles, Quotes, & Charts (NASDAQ:HSIC) - Proactive financial news
Henry Schein stock holds firm after a fresh target lift - ad-hoc-news.de
Henry Schein stock heads into the open after a 1.0% daily loss - ad-hoc-news.de
Henry Schein Executive Andrea Albertini Reports Two Stock Disposals on September 8, 2026 - Kalkine Media
Tax withholding prompts Henry Schein (HSIC) insider to return shares - Stock Titan
Henry Schein stock holds steady after recent earnings update - ad-hoc-news.de
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Precision Trading with Henry Schein Inc. (HSIC) Risk Zones - Stock Traders Daily
Henry Schein stock rises on a new distribution deal - ad-hoc-news.de
Henry Schein to Present at Baird Global Healthcare Conference - dentistrytoday.com
Henry Schein to Distribute Applied BioCode's MDx-3000 System in US - marketscreener.com
Applied BioCode Announces Distribution Agreement with Henry Schein - Business Wire
Henry Schein to Participate in Upcoming Investor Conference in September - Business Wire
How Investors May Respond To Henry Schein (HSIC) Distributing DermaSensor’s Skin Cancer Detection Device - webull.com
Henry Schein stock gains after strong Q2 2026 results and raised outlook - ad-hoc-news.de
Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 9.33% Upside Opportunity in the Medical Distribution Sector - DirectorsTalk Interviews
Henry Schein stock gains institutional support as new diagnostic partnership advances strategy - AD HOC NEWS
Henry Schein Inc. helps children start the school year - Reading Eagle
Henry Schein stock rises after Q2 earnings beat - AD HOC NEWS
Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.00%
2.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):